Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0682 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39591 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2019-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7666d16427ba74d9da7b33937a58877b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c561e7d58e93f58e3a2bf8c995c690d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94775bb30e6dbc9d33df87d5db21fcd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e171f4d14b752efb792d286a29e21f91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9fea5a0b9c14457cd42f06ebe5eb5ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab7055571f9417d83ad1bab0e3cca075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_703ada279c8ab78af79f546f6681fe04 |
publicationDate |
2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-202003574-A |
titleOfInvention |
Antibodies with modulated glycan profiles |
abstract |
This invention relates to recombinantly-expressed denosumab molecules and methods for modulating glycan profiles of denosumab molecules. |
priorityDate |
2018-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |